MEDIFAST INC — Director's Dealing 2025

Jun 26, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2025-06-25

Reporting Person: Xian Ming (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-25	Restricted Stock Units (cash settled)	$	A	11167.65	Acquired		Common Stock (11167.65)	Direct
2025-06-25	Restricted Stock Units (cash settled)	$	A	6013.35	Acquired		Common Stock (6013.35)	Direct

Footnotes

F1: Represents the contingent right to receive shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"). These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Plan.

F2: The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Plan.

F3: The price per share of $13.39 is based on the 20-day moving average price of the Issuer's common stock as of June 6, 2025.